Society ❯Health Trends ❯Obesity Epidemic
Public Health Initiatives Patient Care
The Danish pharmaceutical giant pivots strategically, securing global rights to UBT251 to compete with Eli Lilly's advanced treatments in the expanding weight-loss drug market.
